Let me ask the following question to the board:
Post# of 148189
Why is this the header of the press release (in blue and bold letters ) ???
Why are we in in discussions with MHRA and Health Canada after unblinding (while simultaneously talking to FDA) ???
Where I stand this is far from a "nothing burger" as some are trying to suggest. If the data was not good, would we be "talking" to them ???
Right ???